Add to watchlist
€39.0
Last updated:07/30/2021
1E6: F
Eagle Pharmaceuticals, Inc

Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo an… Show more

P/E ratio
43.67x
vs. 9.54x forward

Price is 43.67x times more than EPS €0.893 which eaquals €39.0

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Mr. Scott L. Tarriff
Market capitalization
Small (0.51B)